Société Tunisienne des Maladies Respiratoires et d'Allergologie STMRA - Case series: Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer

Sté Tunisienne des Maladies Respiratoires et d'Allergologie

Cercle des Bureaux - Appartement B 5-3 . 1082 Centre urbain Nord Tunis

Case series: Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer

Case series: Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer

Zouhair Souissi

Bibliographie

2 décembre 2020

Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer – New England Journal of Medicine

The post Case series: Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer appeared first on Links Medicus.

Lu 828 fois

Taille de police Réduire la taille de la police Augmenter la taille de police

Évaluer cet élément

1
2
3
4
5

(0 Votes)

Plus dans cette catégorie : « Systematic review: Outdoor transmission of SARS-CoV-2 and other respiratory viruses. “The odds of indoor transmission was very high compared to outdoors (18.7 times)” WHO Solidarity Trial: Remdesivir, hydroxychloroquine, lopinavir, and interferon regimens had little or no effect on hospitalized patients with Covid-19 »

About Author

Zouhair Souissi

Dernier de Zouhair Souissi

Recherche